FI893162A0 - Som 19-hydroxylasinhibitorer anvaendbara 19-fluor- eller cyano-21-hydroxiprogesteronderivat. - Google Patents

Som 19-hydroxylasinhibitorer anvaendbara 19-fluor- eller cyano-21-hydroxiprogesteronderivat.

Info

Publication number
FI893162A0
FI893162A0 FI893162A FI893162A FI893162A0 FI 893162 A0 FI893162 A0 FI 893162A0 FI 893162 A FI893162 A FI 893162A FI 893162 A FI893162 A FI 893162A FI 893162 A0 FI893162 A0 FI 893162A0
Authority
FI
Finland
Prior art keywords
cyano
hydroxylasinhibitorer
hydroxiprogesteronderivat
anvaendbara
eller
Prior art date
Application number
FI893162A
Other languages
English (en)
Other versions
FI893162A (fi
Inventor
Gene Warwick Holbert
John O'neal Johnston
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI893162A0 publication Critical patent/FI893162A0/fi
Publication of FI893162A publication Critical patent/FI893162A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Insulating Materials (AREA)
FI893162A 1988-06-28 1989-06-28 Som 19-hydroxylasinhibitorer anvaendbara 19-fluor- eller cyano-21-hydroxiprogesteronderivat. FI893162A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/212,410 US4920114A (en) 1988-06-28 1988-06-28 19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as 19-hydroxylase inhibitors

Publications (2)

Publication Number Publication Date
FI893162A0 true FI893162A0 (fi) 1989-06-28
FI893162A FI893162A (fi) 1989-12-29

Family

ID=22790899

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893162A FI893162A (fi) 1988-06-28 1989-06-28 Som 19-hydroxylasinhibitorer anvaendbara 19-fluor- eller cyano-21-hydroxiprogesteronderivat.

Country Status (19)

Country Link
US (1) US4920114A (fi)
EP (1) EP0348911B1 (fi)
JP (1) JP2727466B2 (fi)
KR (1) KR0140885B1 (fi)
CN (1) CN1039424A (fi)
AT (1) ATE100462T1 (fi)
AU (1) AU610413B2 (fi)
CA (1) CA1321579C (fi)
DE (1) DE68912422T2 (fi)
DK (1) DK318489A (fi)
ES (1) ES2061802T3 (fi)
FI (1) FI893162A (fi)
HU (1) HUT51289A (fi)
IL (1) IL90728A0 (fi)
NO (1) NO892679L (fi)
NZ (1) NZ229694A (fi)
PH (1) PH25771A (fi)
PT (1) PT90989B (fi)
ZA (1) ZA894753B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124574A (en) * 1964-03-10 Iz-halo pregnenes
IT1051705B (it) * 1962-05-12 1981-05-20 Vismara Spa F Metodo per la preparazione di intermedi steroidali
US3154569A (en) * 1961-10-10 1964-10-27 Vismara Francesco Spa 19-nitrilosteroids and process for producing 19-norsteroids
GB984093A (en) * 1962-02-19 1965-02-24 Syntex Corp Improvements in or relating to 19-halo-pregnane compounds
US3257389A (en) * 1962-09-21 1966-06-21 Syntex Corp 19-bisdifluoro-pregnanes
US3257435A (en) * 1962-09-21 1966-06-21 Syntex Corp 19-bisdifluoro pregnanes
US3205228A (en) * 1963-03-01 1965-09-07 Syntex Corp 19-substituted pregnenes
US3159620A (en) * 1963-05-22 1964-12-01 Vismara Francesco Spa Process for the preparation of 17 alpha-ethynyl-19-norandrostene compounds
US3394128A (en) * 1964-09-26 1968-07-23 Syntex Corp 19-halo-androstane and pregnane derivatives and processes for the preparation thereof
FR2462445A1 (fr) * 1979-07-31 1981-02-13 Roussel Uclaf Nouveaux derives 17-/(hydroxymethyl) (formamido) methylene/steroides, leur procede de preparation et leur application a l'introduction de la chaine laterale hydroxyacetyle
US4293548A (en) * 1980-09-02 1981-10-06 Merrell Dow Pharmaceuticals Inc. 18-Substituted pregn-4-ene-3,20-diones

Also Published As

Publication number Publication date
AU610413B2 (en) 1991-05-16
PH25771A (en) 1991-10-18
DK318489D0 (da) 1989-06-27
DE68912422D1 (de) 1994-03-03
FI893162A (fi) 1989-12-29
PT90989B (pt) 1994-11-30
HUT51289A (en) 1990-04-28
NO892679D0 (no) 1989-06-27
EP0348911A3 (en) 1990-03-28
EP0348911A2 (en) 1990-01-03
NZ229694A (en) 1992-03-26
DE68912422T2 (de) 1994-08-18
KR0140885B1 (ko) 1998-06-15
EP0348911B1 (en) 1994-01-19
ATE100462T1 (de) 1994-02-15
US4920114A (en) 1990-04-24
DK318489A (da) 1989-12-29
NO892679L (no) 1989-12-29
ES2061802T3 (es) 1994-12-16
CA1321579C (en) 1993-08-24
JPH0248597A (ja) 1990-02-19
KR900000321A (ko) 1990-01-30
CN1039424A (zh) 1990-02-07
AU3712689A (en) 1990-01-04
JP2727466B2 (ja) 1998-03-11
PT90989A (pt) 1989-12-29
ZA894753B (en) 1990-03-28
IL90728A0 (en) 1990-01-18

Similar Documents

Publication Publication Date Title
NO893076L (no) Fremgangsmaate for fremstilling av aminomethyloxooxa-zolidinylarylbenzenderivater.
NO881138D0 (no) Sammensetning til befrielse av fastsatte borestrenger.
FI896062A0 (fi) Granulat foer kompositioner med kontrollerad frigivning av laekemedel.
DK249389D0 (da) 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer
DK230789A (da) Fremgangsmaade til fremstilling af cytidinderivater
BR8900004A (pt) Composicoes herbicidas de compostos de heterociclicos-alcoilenos de quinoxaliniloxifenoxipropanoato
DK318589A (da) 19-substituerede progesteron-derivater, anvendelige som 19-hydroxylase-inhibitorer
DK250689D0 (da) Fremgangsmaade til fremstilling af napthalenderivater
NO891588D0 (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
FI893162A0 (fi) Som 19-hydroxylasinhibitorer anvaendbara 19-fluor- eller cyano-21-hydroxiprogesteronderivat.
NO895233D0 (no) Fremgangsmaate for fremstilling av di- og tripeptidderivater.
LV5522A3 (lv) Tieno-(3',4',:4,5)-imidazo-(2,1-b)-tiazola atvasinajumu iegusanas panemiens
DK558188D0 (da) Acetylerede pseudoammoniak-, pseudourinstof- eller guanidinderivater, egnede som aktivatorer for oxiderende blegemidler
LV5507A3 (lv) 4,5.-Dihidrooksazolu atvasinajumu iegusanas panemiens

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.